Rossari Biotech Ltd
NSE:ROSSARI
Rossari Biotech Ltd
NSE:ROSSARI
Price:
475
INR
-2.06%
Market Closed
Market Cap:
₹26.3B
Cash Flow Statement
Cash Flow Statement
Rossari Biotech Ltd
Rossari Biotech Ltd
Currency: INR
| Sep-2020 | Mar-2021 | Sep-2021 | Mar-2022 | Sep-2022 | Mar-2023 | Sep-2023 | Mar-2024 | Sep-2024 | Mar-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||||
| Net Income |
935
|
1 064
|
1 273
|
1 363
|
1 396
|
1 442
|
1 562
|
1 776
|
1 884
|
1 852
|
1 859
|
|
| Depreciation & Amortization |
184
|
228
|
300
|
481
|
625
|
629
|
612
|
604
|
617
|
671
|
725
|
|
| Stock-Based Compensation |
0
|
16
|
0
|
18
|
0
|
9
|
0
|
7
|
0
|
1
|
0
|
|
| Other Non-Cash Items |
(27)
|
(18)
|
(4)
|
81
|
227
|
200
|
180
|
160
|
117
|
174
|
165
|
|
| Cash Taxes Paid |
206
|
313
|
414
|
501
|
570
|
478
|
449
|
539
|
579
|
592
|
618
|
|
| Cash Interest Paid |
50
|
39
|
15
|
22
|
36
|
61
|
91
|
160
|
172
|
165
|
202
|
|
| Change in Working Capital |
(47)
|
(797)
|
(1 440)
|
(1 631)
|
(1 259)
|
(756)
|
(1 722)
|
(2 107)
|
(1 456)
|
(1 322)
|
(2 018)
|
|
| Cash from Operating Activities |
1 045
N/A
|
478
-54%
|
129
-73%
|
294
+128%
|
990
+237%
|
1 516
+53%
|
631
-58%
|
433
-31%
|
1 162
+169%
|
1 374
+18%
|
731
-47%
|
|
| Investing Cash Flow | ||||||||||||
| Capital Expenditures |
(848)
|
(581)
|
(471)
|
(382)
|
(261)
|
(329)
|
(973)
|
(1 313)
|
(1 145)
|
(1 585)
|
(2 420)
|
|
| Other Items |
(722)
|
209
|
(2 657)
|
(2 607)
|
(1 035)
|
(1 480)
|
(166)
|
281
|
(259)
|
(252)
|
267
|
|
| Cash from Investing Activities |
(1 570)
N/A
|
(372)
+76%
|
(3 128)
-741%
|
(2 989)
+4%
|
(1 296)
+57%
|
(1 809)
-40%
|
(1 139)
+37%
|
(1 032)
+9%
|
(1 404)
-36%
|
(1 837)
-31%
|
(2 153)
-17%
|
|
| Financing Cash Flow | ||||||||||||
| Net Issuance of Common Stock |
431
|
427
|
3 014
|
3 015
|
33
|
42
|
40
|
38
|
26
|
51
|
34
|
|
| Net Issuance of Debt |
(622)
|
(610)
|
(53)
|
(48)
|
634
|
655
|
602
|
311
|
99
|
791
|
1 770
|
|
| Cash Paid for Dividends |
(25)
|
(25)
|
(25)
|
(28)
|
(30)
|
(28)
|
(28)
|
(28)
|
(28)
|
(28)
|
(28)
|
|
| Other |
947
|
(37)
|
(15)
|
(22)
|
(36)
|
(61)
|
(91)
|
(160)
|
(172)
|
(165)
|
(202)
|
|
| Cash from Financing Activities |
732
N/A
|
(246)
N/A
|
2 922
N/A
|
2 918
0%
|
601
-79%
|
609
+1%
|
524
-14%
|
162
-69%
|
(74)
N/A
|
649
N/A
|
1 574
+143%
|
|
| Change in Cash | ||||||||||||
| Effect of Foreign Exchange Rates |
21
|
0
|
5
|
0
|
4
|
2
|
(3)
|
(3)
|
5
|
4
|
9
|
|
| Net Change in Cash |
228
N/A
|
(140)
N/A
|
(73)
+48%
|
223
N/A
|
299
+34%
|
317
+6%
|
13
-96%
|
(440)
N/A
|
(312)
+29%
|
190
N/A
|
160
-16%
|
|
| Free Cash Flow | ||||||||||||
| Free Cash Flow |
198
N/A
|
(103)
N/A
|
(342)
-231%
|
(89)
+74%
|
729
N/A
|
1 187
+63%
|
(341)
N/A
|
(880)
-158%
|
17
N/A
|
(211)
N/A
|
(1 690)
-702%
|
|
Switch to:
Switch to:
See Also
Discover More
